As the rate-limiting step of this neurotransmitter biosynthesis, mutations in TPH2 have been associated with several PD, such as bipolar disorder, depression, and attention deficit-hyperactivity disorder [11]. The gene discussed is TPH2; the disease is attention deficit-hyperactivity disorder.